Literature DB >> 17289146

B7-1 mediated costimulation regulates pancreatic autoimmunity.

Deepak Yadav1, Cody Fine, Miyuki Azuma, Nora Sarvetnick.   

Abstract

Costimulation by B7-1 and B7-2 molecules results in divergent biological effects. This is particularly striking in the NOD mouse, since the lack of B7-2 leads to complete protection from diabetes whereas the B7-1 deficiency causes exacerbation of disease. We tested the hypothesis that B7-1 costimulation suppresses pancreatic autoimmunity. We describe that the lack of B7-1 not only causes aberrant thymocyte maturation but also significantly enhances expansion, survival, and effector function of islet specific T cells in periphery. We also observed a significant reduction in the proportion of T-regulatory (T-regs) cells. Immunophenotypic analysis of T and APCs revealed a significantly lower frequency of T cells expressing the negative costimulatory receptor PD-1 in B7-1KO mice whereas the proportion of B7-H1 positive APCs was found to be significantly higher. Blocking studies in B7-1KO mice suggest that B7-H1 provides negative signals for anti islet CD4 and CD8 T-cell expansion but is differentially required for their priming. Our data demonstrate that deficiency of B7-1 mediated costimulation causes multitude of immunological defects, which involve reduction in T-regs and a concomitant enhancement of expansion, survival and effector potential of auto reactive T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289146      PMCID: PMC4275027          DOI: 10.1016/j.molimm.2006.12.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  41 in total

1.  Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.

Authors:  S Santra; D H Barouch; S S Jackson; M J Kuroda; J E Schmitz; M A Lifton; A H Sharpe; N L Letvin
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

2.  B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.

Authors:  Tsvetelina Pentcheva-Hoang; Jackson G Egen; Kathleen Wojnoonski; James P Allison
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

3.  Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.

Authors:  A N Schweitzer; F Borriello; R C Wong; A K Abbas; A H Sharpe
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

4.  Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.

Authors:  Masanori Isogawa; Yoshihiro Furuichi; Francis V Chisari
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

Review 5.  The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

6.  B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.

Authors:  Deepak Yadav; Valeria Judkowski; Malin Flodstrom-Tullberg; Lori Sterling; William L Redmond; Linda Sherman; Nora Sarvetnick
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

Review 7.  The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.

Authors:  Samia J Khoury; Mohamed H Sayegh
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

8.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice.

Authors:  S Guerder; D E Picarella; P S Linsley; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells.

Authors:  Jian-Xin Gao; Huiming Zhang; Xue-Feng Bai; Jing Wen; Xincheng Zheng; Jinqing Liu; Pan Zheng; Yang Liu
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

View more
  6 in total

Review 1.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma.

Authors:  Liancai Wang; Qingyong Ma; Xiangli Chen; Kun Guo; Junhui Li; Min Zhang
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

3.  The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.

Authors:  Alison M Paterson; Keturah E Brown; Mary E Keir; Vijay K Vanguri; Leonardo V Riella; Anil Chandraker; Mohamed H Sayegh; Bruce R Blazar; Gordon J Freeman; Arlene H Sharpe
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

4.  Immune sculpting of norepinephrine on MHC-I, B7-1, IDO and B7-H1 expression and regulation of proliferation and invasion in pancreatic carcinoma cells.

Authors:  Liancai Wang; Han Liu; Xiangli Chen; Min Zhang; Keping Xie; Qingyong Ma
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

5.  A Potential Inhibitory Profile of Liver CD68+ Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression.

Authors:  Elias A Said; Iman Al-Reesi; Marwa Al-Riyami; Khalid Al-Naamani; Shadia Al-Sinawi; Mohammed S Al-Balushi; Crystal Y Koh; Juma Z Al-Busaidi; Mohamed A Idris; Ali A Al-Jabri
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

Review 6.  Dichotomous roles of co-stimulatory molecules in diabetes mellitus.

Authors:  Ji-Xin Zhong; Jie Chen; Xiaoquan Rao; Lihua Duan
Journal:  Oncotarget       Date:  2017-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.